Author:
Loo Gan Chun,Huang Jiaming,Pan Elizabeth,Xie Wanling,Schmidt Andrew L.,Labaki Chris,Meza Luis,Bouchard Gabrielle,Li Haoran,Jackson-Spence Francesca,Sánchez-Ruiz Carla,Powles Thomas,Kumar Shruti A.,Weise Nicole,Hall William A.,Rose Brent S.,Beuselinck Benoit,Suarez Cristina,Pal Sumanta K.,Choueiri Toni K.,Heng Daniel Y.C.,McKay Rana R.
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference16 articles.
1. Pazopanib combined with radiation: in vivo model of interaction;Meredith;Cancer Biother Radiopharm,2014
2. Immunologically augmented cancer treatment using modern radiotherapy;Durante;Trends Mol Med,2013
3. Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial;De Wolf;Radiat Oncol,2017
4. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth;Yakes;Mol Cancer Ther,2011
5. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial;Choueiri;Lancet Oncol,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献